Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV
· Real-Time Price · USD
1.03
-0.01 (-1.44%)
At close: Sep 25, 2025, 3:59 PM
1.03
0.00%
After-hours: Sep 25, 2025, 05:08 PM EDT
-1.44% (1D)
| Bid | 1.02 |
| Market Cap | 24.56M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.1M |
| EPS (ttm) | -0.57 |
| PE Ratio (ttm) | -1.81 |
| Forward PE | -1.82 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.08 |
| Volume | 137,962 |
| Avg. Volume (20D) | 542,687 |
| Open | 1.03 |
| Previous Close | 1.04 |
| Day's Range | 1.02 - 1.05 |
| 52-Week Range | 0.81 - 2.10 |
| Beta | 0.83 |
| Ex-Dividend Date | n/a |
About ENLV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENLV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENLV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts9 months ago
+20.37%
Elivex Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
10 months ago
-5.24%
Enlivex Therapeutics shares are trading higher after the company announced its board approved the purchase of up to $1 million in Bitcoin.
